VAV3 and triple-negative breast carcinoma: As a guanine nucleotide exchange factor, VAV3 relates to the pathophysiology of triple-negative breast cancer (TNBC) by promoting cytoskeletal remodeling and metastatic potential through activation of Rho family GTPases.